Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hainan Jimin Boao International Hospital Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. JACKSON III, WALTER is the busiest examiner for the company, managing the 1 pending action. This action represents the entire current pending workload for the hospital's patent portfolio. The concentration of the prosecution into a single examiner and art unit indicates a focused technical matter.
For a practitioner, this indicates that the immediate prosecution strategy is entirely centralized under JACKSON III, WALTER. The lack of multiple examiners or art units simplifies the management of this portfolio, as there are no competing timelines or differing examiner styles to navigate across the 1 pending action. This centralized approach ensures that all communication and negotiation with the patent office are handled by a single individual within the Biotechnology & Pharmaceuticals field. The 1 pending action serves as the focal point for the company's current efforts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JACKSON III, WALTER | 1 | 50.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19027793 | METHOD FOR CULTURING DENDRITIC CELLS THROUGH AMPLIFICATION AND DIFFERENTIATION OF PERIPHERAL BLOOD, AND USAGE THEREOF | JACKSON III, WALTER | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19027793 | METHOD FOR CULTURING DENDRITIC CELLS THROUGH AMPLIFICATION AND DIFFERENTIATION OF PERIPHERAL BLOOD, AND USAGE THEREOF | JACKSON III, WALTER | 1638 | §101§103§112 | Non-Final OA | — | Pending | Jan 17, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHainan Jimin Boao International Hospital Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Walter Jackson III has the most, with 1 of Hainan Jimin Boao International Hospital Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
